{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:23Z","timestamp":1761058403705},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T00:00:00Z","timestamp":1266451200000},"content-version":"vor","delay-in-days":1508,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2006,1,2]]},"abstract":"<jats:p>A transition from methadone to buprenorphine without intervening withdrawal symptoms is critical for advancing the treatment of opioid\u2010dependent patients. Four pregnant inpatients were transferred from methadone (65\u201385 mg) to five days of immediate release morphine (IRM) and then to buprenorphine (12\u201328 mg). Withdrawal scores decreased during the five days of IRM and subsequently increased over the first three days on buprenorphine. The transitional use of IRM appears safe for both mother and fetus. Withdrawal symptoms appeared during buprenorphine induction; however, these data suggest that the intensity of withdrawal symptoms may be lessened by the dose and frequency of buprenorphine administration.<\/jats:p>","DOI":"10.1080\/10550490500419094","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T22:33:12Z","timestamp":1138746792000},"page":"61-70","source":"Crossref","is-referenced-by-count":16,"title":["Transferring Methadone\u2010Stabilized Pregnant Patients to Buprenorphine Using an Immediate Release Morphine Transition: An Open\u2010Label Exploratory Study"],"prefix":"10.1111","volume":"15","author":[{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Suess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Jasinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolley E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"e_1_2_6_3_2","volume-title":"Treatment Improvement Protocol (TIP) Series 40, DHHS Publication Number (SMA) 04\u20133939","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246290"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00071-1"},{"key":"e_1_2_6_6_2","first-page":"628","article-title":"Buprenorphine effects in methadone\u2010maintained volunteers: effects at two hours after methadone","volume":"272","author":"Strain EC","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052035"},{"key":"e_1_2_6_8_2","volume-title":"Clinical guidelines: bupre\u2010norphine treatment of heroin dependence","author":"Lintzeris N"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00071-1"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(94)90059-0"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000052040"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.95223910.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.1997.tb00559.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00032-0"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00056-5"},{"key":"e_1_2_6_16_2","first-page":"449","article-title":"Buprenorphine's physical dependence potential: antagonist\u2010precipitated withdrawal in humans","volume":"276","author":"Eissenberg T","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750320112017"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.181.1.1887021"},{"key":"e_1_2_6_19_2","unstructured":"KummS http:\/\/classes.kumc.edu\/son\/nurs420\/unit11\/FHT.htm. Accessed: July 2003."},{"key":"e_1_2_6_20_2","volume-title":"Williams Obstetrics","author":"Pritchard J","year":"1985"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.147"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.93454910.x"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F10550490500419094","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/10550490500419094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T18:15:18Z","timestamp":1697566518000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1080\/10550490500419094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,2]]}},"alternative-id":["10.1080\/10550490500419094"],"URL":"https:\/\/doi.org\/10.1080\/10550490500419094","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,2]]}}}